“Unraveling the Legal Labyrinth: Can AI Revolutionize Pharma Without Copyright Catastrophes?”
As we plunge deeper into the realm of artificial intelligence, the life sciences sector is revving its engines at full throttle. A recent survey conducted by the Pistoia Alliance reveals that a staggering 83% of professionals are leveraging generative AI in their day-to-day tasks! Now, that’s a sign of the times — or perhaps just a sign that I need to brush up on my own AI knowledge! The hype around AI’s capacity to transform drug development and clinical research is palpable. However, this whirlwind of advancement isn’t without its pitfalls. As we rush headlong into adopting these technologies, it’s crucial to pause and ask: Are we fully grasping the rules of engagement? Enter the ongoing concerns surrounding copyright and compliance, which are often lurking in the shadows as organizations sprint toward AI integration. Join me as we unpack the complexities of using AI responsibly in our industry, starting with the critical necessity of copyright compliance. The future of innovation depends on it. LEARN MOREBy Becky Upton, Ph.D., president, Pistoia Alliance
